Skip to main content

Rosetta Biosoftware to Make Elucidator Compatible With Waters' Mass Specs

NEW YORK (GenomeWeb News) — Waters and Rosetta Biosoftware plan to develop interfaces that will make Rosetta's software compatible with two of Waters' mass spectrometers, the companies said today.
 
Terms of the deal call for the companies to make Rosetta Biosoftware's Elucidator software for protein expression data management work with Waters' Q-Tof Premier and Synapt high-definition mass spectrometers.
 
The resulting compatibility will allow Waters customers to "take advantage of our mass spec technologies to comprehensively analyze the results of their most demanding experiments," said Tim Riley, vice president and managing director of Waters’ pharmaceutical business, in a statement.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.